Atlas Trials

Li-kun Chen

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Li-kun Chen

RecordFirmDate
Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Nonsquamous NSCLC With Brain Metastasis (NCT07197008)Li-kun Chen2025-10-01
Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study (NCT06728852)Li-kun Chen2024-12-01
Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study (NCT06728865)Li-kun Chen2024-09-04
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer (NCT04978753)Li-kun Chen2021-05-01

Track Li-kun Chen automatically

Every clearance here is in the API, with alerts when new ones post.